Swixx Biopharma
Baar, CH · 1,602 employees · 5 known investors
Find your way into Swixx Biopharma
Sign up to find every way you can get introduced to Swixx Biopharma
- Your email: who you already know at Swixx Biopharma, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Swixx Biopharma team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Swixx BioPharma is a specialized pharmaceutical distributor and market access partner that represents international biopharma, OTC, and medical device companies in markets across Central & Eastern Europe, the Middle East, North Africa, Latin America, and Eurasia. The company operates as an indirect route-to-market solution for healthcare companies seeking regional expansion without establishing their own subsidiaries.
Investors · 5
How we know: the company's own site · Bain Capital Life Sciences's portfolio page · Not right? Tell us
How we know: the company's own site · HBM Partners's portfolio page · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
Frequently asked questions
- What does Swixx Biopharma do?
- Swixx BioPharma is a specialized pharmaceutical distributor and market access partner that represents international biopharma, OTC, and medical device companies in markets across Central & Eastern Europe, the Middle East, North Africa, Latin America, and Eurasia. The company operates as an indirect route-to-market solution for healthcare companies seeking regional expansion without establishing their own subsidiaries.
- Who are Swixx Biopharma's investors?
- Swixx Biopharma's investors include Bain Capital Life Sciences, HBM Partners, Mérieux Equity Partners, SK Capital Partners, HBM Healthcare Investments.
- Where is Swixx Biopharma headquartered?
- Swixx Biopharma is headquartered in Baar, CH.

